Free Trial

IMAC Q2 2024 Earnings Report

IMAC logo
$1.36 +0.04 (+3.03%)
As of 03:58 PM Eastern

IMAC EPS Results

Actual EPS
-$1.74
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

IMAC Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

IMAC Announcement Details

Quarter
Q2 2024
Time
Before Market Opens

Conference Call Resources

IMAC Earnings Headlines

Do this Before Elon’s Reveal on January 29th
Elon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but designed to power a $9 trillion AI revolution. And I’ve identified a little-known supplier Elon is depending on to make it all happen.
See More IMAC Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like IMAC? Sign up for Earnings360's daily newsletter to receive timely earnings updates on IMAC and other key companies, straight to your email.

About IMAC

IMAC (NASDAQ:BACK) owns and manages innovative medical advancements and care regeneration centers, and backspace clinics in the United States. The company's outpatient medical clinics provide regenerative, orthopedic, and minimally invasive procedures and therapies to patients with sports injuries, ligament and tendon damage, and other related soft tissue conditions, as well as back, knee, and joint pains. It also provides medical treatments, regenerative, spinal decompression, chiropractic manipulation, and physical medicine and therapy. IMAC Holdings, Inc. was founded in 2000 and is headquartered in Franklin, Tennessee.

View IMAC Profile

More Earnings Resources from MarketBeat